Scorpion Venom Yields Clues for Developing Better Pharmaceuticals
- Details
- Written by Trina Wood
- Category: Health News
Davis, California - Normally, people consider scorpions to be dangerous because of their venomous sting, but an international group of researchers recently discovered that a particular family of toxins, the calcins, found in some venom, might also have a unique beneficial function.
Visualizing and predicting evolution by mapping the elusive 'fitness landscape'
- Details
- Written by Jim Erickson
- Category: Health News
Ann Arbor, Michigan - Suppose you were trying to design a vaccine to combat next season's influenza virus. Having a detailed map that tells you exactly how various strains of the flu bug will evolve would be extremely helpful.
American Heart Association Issues “Red Steps Challenge” to Rise Above Heart Failure
- Details
- Written by IVN
- Category: Health News
Dallas, Texas - The American Heart Association is calling on people to take six million “red steps” in recognition of the nearly six million Americans living with heart failure (HF).
SPF30 Sunscreens Delay Melanoma Incidence in Preclinical Model
- Details
- Written by IVN
- Category: Health News
New Orleans, Louisiana - Application of sun protection factor 30 (SPF30) sunscreen prior to exposure to ultraviolet-B (UVB) light delayed melanoma onset in a mouse model of the disease, according to research presented here at the AACR Annual Meeting 2016, April 16-20. These data suggest that the mouse model can be used to identify new, more effective melanoma-preventing agents.
American Cancer Society and IBM Collaborate to Create Virtual Cancer Health Advisor
- Details
- Written by IVN
- Category: Health News
Atlanta, Georgia - IBM and the American Cancer Society today announced a partnership to create the first advisor for people fighting cancer, powered by Watson cognitive computing. The initiative, announced at the 13th Annual World Health Care Congress, aims to provide cancer patients, survivors, and caregivers with trusted ACS resources and guidance personalized to an individual's unique journey against cancer.
Stand Up To Cancer Launches “Catalyst,” a New Research Program Supported by Industry
- Details
- Written by AACR
- Category: Health News
Los Angeles, California - Stand Up To Cancer (SU2C), the charitable initiative aimed at bringing new treatments to cancer patients quickly, today announced Catalyst, a new program that will use funding and materials from the pharmaceutical, biotechnology, diagnostic and medical devices industries to accelerate research on cancer prevention, detection and treatment. Founding collaborator Merck; and Bristol-Myers Squibb Company, and Genentech, a member of the Roche Group, are Charter Supporters.
Page 3025 of 3785